SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories informs about closure of trading window

29 Dec 2023 Evaluate
Zim Laboratories has informed that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, and Company’s Code of Conduct to Regulate, Monitor and Report Trading by Insider’s, the trading window for dealing with securities of the Company will remain closed from Monday, the 01st January, 2024, for ‘Designated Persons’, including Promoters, Directors, Key Managerial Personnel, connected person, Designated employees of the company and their immediate relatives. The Trading Window shall open post 48 hours from the declaration of financial results of the company for the quarter and nine months ended 31st December, 2023.

The above information is a part of company’s filings submitted to BSE.

Zim Laboratories Share Price

79.72 3.72 (4.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×